This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Zysis Limited. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Russell Pendleton: Innovator in Pharmaceutical Compositions
Introduction
Russell Pendleton is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on aripiprazole. His expertise and dedication to advancing medical treatments have positioned him as a key figure in the industry.
Latest Patents
Pendleton holds a patent for a pharmaceutical composition of aripiprazole. This orally deliverable composition provides controlled release of the drug, which includes a therapeutically effective amount of aripiprazole and at least one pharmaceutically acceptable excipient. The compositions he developed may exhibit various release profiles as defined in the specification, showcasing his innovative approach to drug formulation.
Career Highlights
Throughout his career, Pendleton has been associated with Zysis Limited, where he has contributed to the development of cutting-edge pharmaceutical solutions. His work has not only advanced the understanding of drug delivery systems but has also improved patient outcomes through more effective medication options.
Collaborations
Pendleton collaborates with Ian Wilding, leveraging their combined expertise to drive innovation in pharmaceutical research and development.
Conclusion
Russell Pendleton's contributions to pharmaceutical compositions, particularly in the controlled release of aripiprazole, highlight his role as an influential inventor in the field. His work continues to impact the pharmaceutical industry positively.